BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1243401)

  • 1. [Evidence of serum HPL level for prognosis of threatening abortion].
    Tykal P; Rüssler R; Dittmar FW
    Arch Gynakol; 1975 Nov; 219(1-4):418-9. PubMed ID: 1243401
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic value of human placental lactogen (HPL) levels in threatened abortion.
    Gartside MW; Tindall VR
    Br J Obstet Gynaecol; 1975 Apr; 82(4):303-9. PubMed ID: 1125152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol, estriol and human placental lactogen in serum in threatened abortion.
    Hertz JB; Larsen JF; Svenstrup B; Johnsen SG
    Acta Obstet Gynecol Scand; 1979; 58(4):365-70. PubMed ID: 525270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human placental lactogen (HPL) in serum in complicated early pregnancy.
    Ylikorkala O; Jouppila P
    J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1040-5. PubMed ID: 4761378
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is there any evidence that the maternal HPL serum-concentration is of prognostic value in cases of threatened abortion? (author's transl)].
    Berle P; Behnke K
    Z Geburtshilfe Perinatol; 1977 Jun; 181(3):211-7. PubMed ID: 888497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of measurements of maternal serum hCG, hPL and progesterone as prognostic markers of abortion in early pregnancy.
    Sugita N; Yamaji K; Takagi T; Chiba Y; Tanizawa O
    Asia Oceania J Obstet Gynaecol; 1983 Mar; 9(1):49-54. PubMed ID: 6860237
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental lactogen levels in threatened abortion.
    Niven PA; Chard T
    Proc R Soc Med; 1973 Feb; 66(2):188. PubMed ID: 4714661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of radioimmunologic determination of placental lactogen hormone to the prognosis of spontaneous threatened abortion].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):331-04. PubMed ID: 4681537
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of imminent abortion with monitoring of the maternal serum HPL level (proceedings)].
    Berle P; Behnke K
    Arch Gynakol; 1977 Jul; 224(1-4):90-1. PubMed ID: 341834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical value of radioimmunological HPL findings in the long-term care of threatened abortion].
    Ruckhäberle KE; Bilek K; Viehweg B; Kühndel K; Colditz U; Bär G
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():43-9. PubMed ID: 6242693
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion.
    Genazzani AR; Aubert ML; Casoli M; Fioretti P; Felber JP
    Lancet; 1969 Dec; 2(7635):1385-7. PubMed ID: 4188275
    [No Abstract]   [Full Text] [Related]  

  • 14. Human placental lactogen as an index of placental function.
    Zuckerman H; Gendler L; Schwarz M; Harpaz S
    Isr J Med Sci; 1974 May; 10(5):490-4. PubMed ID: 4413719
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the outcome of pregnancy in threatened abortion by biochemical methods.
    Karjalainen O; Stenman U; Wichmann K; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(6):457-64. PubMed ID: 4140705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1975 Jan; 121(2):257-61. PubMed ID: 46714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunological assessment of the placental lactogen concentration in threatened abortion].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6242695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of HPL radioimmunoassay in normal and pathologic early pregnancy].
    Hör G; Wallner H; Pabst HW; Domanowsky W
    Nucl Med (Stuttg); 1975 Jan; 13(4):371-8. PubMed ID: 1114050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortion.
    Kunz J; Keller PJ
    Br J Obstet Gynaecol; 1976 Aug; 83(8):640-4. PubMed ID: 60125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioimmunologic determination of placental lactogenic hormone in threatened spontaneous abortion. Prognostic value compared with determination of chorionic gonadotrophic hormone (HCG)].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(1):53-62. PubMed ID: 4807227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.